Chelsea to Conduct Further Trial to Show Effectiveness of Northera

Chelsea to Conduct Further Trial to Show Effectiveness of Northera

It has been reported that the Food and Drug Administration of the US has asked the manufacturer of Northera, a low-blood-pressure medication to provide with more proves to show that the medication is effective in treating low-blood-pressure.

Following the revelation, the shares of Chelsea Therapeutics International Ltd. (CHTP) fell down significantly. The Food and Drug Administration has expressed doubts over the benefits of the medication.

Last month, the advisory committee of the Food and Drug Administration voted against the medication. Since then, the manufacturer has been in talks with the authorities. It has been informed that the controversial drug, Northera, is already being sold in Japan for past 20 years.

The Food and Drug Administration has said that the drug taken by patients for weeks doesn’t leaves effective effect on the patient health. The manufacturer has informed that the drug is capable of controlling the problem of low-blood-pressure for two or three months.

The Food and Drug Administration have also recommended of labeling on the medication package. The labeling, as recommended by the administration, should clearly highlight that a patient taking the drug would experience dizziness and lightheadedness.

Chelsea said that it would be working as per the guidelines of the authorities. The company has estimated that within five years of its sales, the firm can book revenue of 300 million to $375 million. However, it is yet not clear as to when the drug would be launched.

The company would be conducting yet another trial to show the effectiveness of the drug in treating low-blood-pressure. It has been informed that the drug has an orphan status. It means that the drug has the potential of treating a rare type of health problem which affects 200,000 Americans.


FrenchTribune Specials

Frog, Toad Species Declared Endangered

Additional protection has been granted to two species of yellow-legged frogs and one species of toad, all of whom dwell in Yosemite National Park, which is located in California. The federal authorities have pronounced that the almost 3,000 square miles of the national park in the state’s Sierra Nevada mountains is the critical habitat for the...

Most Popular

Playing a wind instrument could damage your lungs, UK doctors warn

The UK doctors have warned trumpeters, saxophonists and...

Socio-economic factors define survival among people with multiple myeloma

A study published in Cancer found that it is not race...

Pine Tree Named ‘Adonis’ Is Oldest European Tree in Greece

Greece has been home to the oldest tree in the Europe,...

Vehicle ran over Threatened Green Sea Turtle While it Was Nesting, Probe On

Green turtles that are threatened species need to be...

Poll

Can Greece Come out of Economic Problems: